These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18435429)

  • 21. Optimal and maximin sample sizes for multicentre cost-effectiveness trials.
    Manju MA; Candel MJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):513-39. PubMed ID: 25656551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient treatment allocation in two-way nested designs.
    Lemme F; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):494-512. PubMed ID: 24030312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of information methods for planning and analyzing clinical studies optimize decision making and research planning.
    Willan AR; Goeree R; Boutis K
    J Clin Epidemiol; 2012 Aug; 65(8):870-6. PubMed ID: 22609138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of information methods to design a clinical trial in a small population to optimise a health economic utility function.
    Pearce M; Hee SW; Madan J; Posch M; Day S; Miller F; Zohar S; Stallard N
    BMC Med Res Methodol; 2018 Feb; 18(1):20. PubMed ID: 29422021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health technology assessment, value-based decision making, and innovation.
    Henshall C; Schuller T;
    Int J Technol Assess Health Care; 2013 Oct; 29(4):353-9. PubMed ID: 23845404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments.
    Manca A; Sculpher MJ; Goeree R
    Pharmacoeconomics; 2010; 28(12):1079-96. PubMed ID: 21080734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology.
    Davies L; Coyle D; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1601-7. PubMed ID: 8047917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of information and optimal clinical trial design.
    Willan AR; Pinto EM
    Stat Med; 2005 Jun; 24(12):1791-806. PubMed ID: 15806619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness research in radiology.
    Hunink MG
    Acad Radiol; 1996 Apr; 3 Suppl 1():S13-6. PubMed ID: 8796498
    [No Abstract]   [Full Text] [Related]  

  • 31. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers.
    Glynn RJ; Brookhart MA; Stedman M; Avorn J; Solomon DH
    Med Care; 2007 Oct; 45(10 Supl 2):S38-43. PubMed ID: 17909381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budgeting of non-commercial clinical trials: development of a budget tool by a public funding agency.
    Nevens H; Harrison J; Vrijens F; Verleye L; Stocquart N; Marynen E; Hulstaert F
    Trials; 2019 Dec; 20(1):714. PubMed ID: 31829233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical decision making and the expected value of information.
    Willan AR
    Clin Trials; 2007; 4(3):279-85. PubMed ID: 17715257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decision rules and associated sample size planning for regional approval utilizing multiregional clinical trials.
    Chen X; Lu N; Nair R; Xu Y; Kang C; Huang Q; Li N; Chen H
    J Biopharm Stat; 2012 Sep; 22(5):1001-18. PubMed ID: 22946946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Tutorial on Value-Based Adaptive Designs: Could a Value-Based Sequential 2-Arm Design Have Created More Health Economic Value for the Big CACTUS Trial?
    Flight L; Brennan A; Wilson I; Chick SE
    Value Health; 2024 Oct; 27(10):1328-1337. PubMed ID: 38977182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brief report: a cost analysis of neuraxial anesthesia to facilitate external cephalic version for breech fetal presentation.
    Carvalho B; Tan JM; Macario A; El-Sayed YY; Sultan P
    Anesth Analg; 2013 Jul; 117(1):155-9. PubMed ID: 23592608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding Health Technology Assessments to Include Effects on the Environment.
    Marsh K; Ganz ML; Hsu J; Strandberg-Larsen M; Gonzalez RP; Lund N
    Value Health; 2016; 19(2):249-54. PubMed ID: 27021760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of research networks to a clinical trial of antidepressants in people with dementia.
    McCrae N; Douglas L; Banerjee S
    J Ment Health; 2012 Oct; 21(5):439-47. PubMed ID: 22548261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing clustering effects and learning effects in the design and analysis of multicentre randomised trials: a survey to establish current practice.
    Conroy EJ; Blazeby JM; Burnside G; Cook JA; Gamble C
    Trials; 2020 May; 21(1):433. PubMed ID: 32460815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health technology assessment in the cost-disutility plane.
    Eckermann S; Briggs A; Willan AR
    Med Decis Making; 2008; 28(2):172-81. PubMed ID: 18356312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.